MARKETS / US / RSCF
US · LABORATORY APPARATUS & FURNITURE · SMALL CAP

Reflect Scientific, Inc. RSCF

14 fiscal years on record · USD · FY2023 reported
SEC FILINGS ONLY
Revenue · FY2023
$1.1M
▼ 47.1% vs FY2022
EPS · FY23
$-0.01
Dividend / sh · FY23
Payout · FY23
ROE · FY23
-21.9%
Net margin · FY23
-42.5%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.1M
Revenue, FY2023 · full 14-year series below
Revenue Net income
0.00080.00160.00240.00320.0-0.0201020132016201920222023
0.00080.00160.00240.00320.0-0.02014201720202023

The company lost 42 cents on every revenue dollar this year.

Per share
USD -0.01
Diluted EPS, FY2023
EPS
0.40.81.2-0.01201020132016201920222023
0.40.81.2-0.012014201720202023

The company pays no cash dividend.

Profitability
-21.9%
Return on equity, FY2023
ROE
20406080-21.9%201020132016201920222023
20406080-21.9%2014201720202023
Operating margin-43.3%
Net margin-42.5%
Return on assets-17.9%

Each USD of equity lost 22 cents this year.

Returned to shareholders
returned in FY2023 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
−7.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−27.1%
−7.0%
−1.7%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.09B
Shares outstanding, FY2023
0.030.09201020132016201920222023
0.060.092014201720202023
Change, 5 years+8.3%
Change, 10 years+59.4%

The share count grew 8% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.7M
total assets, end of FY2023
Total assetsUSD 2.7M
EquityUSD 1.9M
CashUSD 1.3M
Current ratio3.97×

Equity funds 71% of total assets.

History
14 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
·
·
·
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
·
·
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
EPS, diluted $
−0.01
0.00
0.01
0.01
0.00
0.00
−0.01
0.00
0.01
−0.02
−0.02
0.00
−0.03
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−21.9
4.0
55.4
74.8
−35.4
−46.6
−82.7
−42.8
·
·
·
·
−2656.1
−136.0
Shares out B
0.09
0.09
0.08
0.08
0.08
0.08
0.07
0.07
0.06
0.06
0.05
0.05
0.04
0.03

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
48 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 1 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed